CLINICAL_TRIALS
trial_result
· 2021-05-17
Clinical Trial Update: Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) [Phase 2]
Summary
Phase 2 trial update evaluating the efficacy and safety of BMS-986165 compared with placebo in active psoriatic arthritis; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Active Psoriatic Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2021-05-17